Drug Trial Radar · NCT00387309
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
495
Actual
Start
Dec 2006
Primary completion
Not stated
Study completion Nov 2007
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 13, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.
Conditions
- Post Operative Bowel Dysfunction
Interventions
Methylnaltrexone (MOA-728)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the MOA-728 regimen than with a placebo regimen.
Locations
92 sites in 10 countries. Site status is shown where the registry gives one.
Site not named
Mobile, Alabama
Site not named
Fort Smith, Arkansas
Site not named
Chula Vista, California
Site not named
Colton, California
Site not named
Los Angeles, California
Site not named
Oceanside, California
Site not named
Palo Alto, California
Site not named
San Jose, California
Site not named
Torrance, California
Site not named
Denver, Colorado
Site not named
Washington D.C., District of Columbia
Site not named
Bay Minette, Florida
Site not named
Jacksonville, Florida
Site not named
Melbourne, Florida
Site not named
Naples, Florida
Site not named
St. Petersburg, Florida
Site not named
Vero Beach, Florida
Site not named
Weston, Florida
Site not named
Atlanta, Georgia
Site not named
Atlanta, Georgia
Site not named
Marietta, Georgia
Site not named
Chicago, Illinois
Site not named
Chicago, Illinois
Site not named
Naperville, Illinois
Site not named
Park Ridge, Illinois
Site not named
Kansas City, Kansas
Site not named
Lexington, Kentucky
Site not named
New Orleans, Louisiana
Site not named
Hagerstown, Maryland
Site not named
Boston, Massachusetts
Site not named
Saint Paul, Minnesota
Site not named
Saint Paul, Minnesota
Site not named
Albany, New York
Site not named
Kingston, New York
Site not named
New York, New York
Site not named
New York, New York
Site not named
Syracuse, New York
Site not named
Chapel Hill, North Carolina
Site not named
Cleveland, Ohio
Site not named
Columbus, Ohio
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.